Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families

Converting Enzyme ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Receptor Blocking ◽

Pressure Lowering ◽

Plant Families

Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor

Circulation ◽

10.1161/circulationaha.106.642058 ◽

2007 ◽

Vol 115 (6) ◽

pp. 725-732 ◽

Cited By ~ 51

Author(s):

Xiaowen Su ◽

Liming Lee ◽

Xiaohui Li ◽

Jun Lv ◽

Yonghua Hu ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Blood Pressure Response ◽

Pressure Response ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitor

Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY)

Clinical and Experimental Hypertension ◽

10.3109/10641963.2012.681081 ◽

2012 ◽

Vol 34 (4) ◽

pp. 249-257 ◽

Cited By ~ 4

Author(s):

Akinobu Maeda ◽

Kouichi Tamura ◽

Tomohiko Kanaoka ◽

Masato Ohsawa ◽

Sona Haku ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Combination Therapy ◽

Calcium Channel ◽

Channel Blocker ◽

Therapeutic Effects ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

S 05985 combination versus angiotensin II receptor blocker/calcium channel blocker: a comparison of blood pressure lowering - efficacy and safety

http://isrctn.org/> ◽

10.1186/isrctn59214686 ◽

2013 ◽

Author(s):

G. Mancia

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Efficacy And Safety ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitors

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd010053 ◽

2012 ◽

Cited By ~ 1

Author(s):

Imran Sumar ◽

Farah Kassam ◽

Colin Dormuth ◽

James M Wright

Keyword(s):

Blood Pressure ◽

Time Course ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Blood Pressure Lowering ◽

Converting Enzyme Inhibitors ◽

Angiotensin II receptor blocker provides pancreatic ?-cell protection independent of blood pressure lowering in diabetic db/db mice

Acta Pharmacologica Sinica ◽

10.1111/j.1745-7254.2007.00492.x ◽

2007 ◽

Vol 28 (2) ◽

pp. 246-257 ◽

Cited By ~ 9

Author(s):

Jia-qing SHAO ◽

Noseki IWASHITA ◽

Hong DU ◽

Yang-tian WANG ◽

Yan-yan WANG ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Cell Protection ◽

Pancreatic Cell ◽

Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist

Drug Development Research ◽

10.1002/ddr.430330405 ◽

1994 ◽

Vol 33 (4) ◽

pp. 422-428 ◽

Cited By ~ 13

Author(s):

Anthony A. Fossa ◽

Michael J. Depasquale ◽

Laura J. Ringer ◽

Roxanne L. Winslow

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Synergistic Effect ◽

Angiotensin Ii Receptor Antagonist

Receptor Antagonist ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

High dose treatment with angiotensin II receptor blocker in patients with hypertension: Differential effect of tissue protection versus blood pressure lowering

Atherosclerosis ◽

10.1016/j.atherosclerosis.2006.12.036 ◽

2008 ◽

Vol 197 (1) ◽

pp. 303-310 ◽

Cited By ~ 11

Author(s):

M. Shargorodsky ◽

E. Hass ◽

M. Boaz ◽

D. Gavish ◽

R. Zimlichman

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Differential Effect ◽

High Dose ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Tissue Protection ◽

High Dose Treatment ◽

Regression of intima media thickness and intima media area with blood pressure lowering by calcium channel blockade and angiotensin converting enzyme inhibition

American Journal of Hypertension ◽

10.1016/s0895-7061(00)00715-9 ◽

2000 ◽

Vol 13 (6) ◽

pp. S206-S207

Author(s):

A Stanton

Keyword(s):

Blood Pressure ◽

Intima Media Thickness ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Channel Blockade ◽

Blood Pressure Lowering ◽

Calcium Channel Blockade ◽

Pressure Lowering ◽

Converting Enzyme Inhibition

Is there relationship between the A1166C polymorphism of the angiotensin II receptor AT1 and plasma renin activity, insulin resistance and reduction of blood pressure after angiotensin‑converting enzyme inhibitor therapy?

Polish Archives of Internal Medicine ◽

10.20452/pamw.358 ◽

2008 ◽

Vol 118 (4) ◽

pp. 194-200

Author(s):

Jerzy Głuszek ◽

Karolina Jankowska

Keyword(s):

Insulin Resistance ◽

Blood Pressure ◽

Angiotensin Ii ◽

Plasma Renin Activity ◽

Enzyme Inhibitor ◽

Plasma Renin ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

A1166c Polymorphism

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria

Nephrology Dialysis Transplantation ◽

10.1093/ndt/17.4.597 ◽

2002 ◽

Vol 17 (4) ◽

pp. 597-601 ◽

Cited By ~ 60

Author(s):

Priscilla Kincaid‐Smith ◽

Kenneth Fairley ◽

David Packham

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Renal Disease ◽

Enzyme Inhibitor ◽

Chronic Renal Disease ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Randomized Controlled